AFT Pharmaceuticals Wins Court of Appeal Case Over Pascomer Profits

MT Newswires Live

03/09

AFT Pharmaceuticals (ASX:AFP, NZE:AFT) said that the court of appeal has dismissed PBL Solutions' bid to claim a share of profits from the company's use of its topical skin medicine Pascomer for treating port wine stains (PWS), according to a Monday filing with the Australian and New Zealand bourses.

The ruling allows the company to retain full profits from Pascomer's use in treating non-orphan conditions like PWS, per the filing.

PBL, holding a 35% stake in AFT Orphan Pharmaceuticals, will receive 35% of any profits from Pascomer orphan drug applications, the filing said.

PBL and the company will share the appeal costs, and the company does not expect the judgment to materially affect its fiscal year 2026 earnings guidance, the filing added.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2618692420"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618692420\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618692420?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 08:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618692420","market":"nz","top_or_hot":-1,"title":"AFT Pharmaceuticals Wins Court of Appeal Case Over Pascomer Profits","media":"MT Newswires Live","content":"<html><body><p> AFT Pharmaceuticals (ASX:AFP, NZE:AFT) said that the court of appeal has dismissed PBL Solutions' bid to claim a share of profits from the company's use of its topical skin medicine Pascomer for treating port wine stains (PWS), according to a Monday filing with the Australian and New Zealand bourses.</p><p>The ruling allows the company to retain full profits from Pascomer's use in treating non-orphan conditions like PWS, per the filing.</p><p>PBL, holding a 35% stake in AFT Orphan Pharmaceuticals, will receive 35% of any profits from Pascomer orphan drug applications, the filing said.</p><p>PBL and the company will share the appeal costs, and the company does not expect the judgment to materially affect its fiscal year 2026 earnings guidance, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AFT Pharmaceuticals Wins Court of Appeal Case Over Pascomer Profits</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAFT Pharmaceuticals Wins Court of Appeal Case Over Pascomer Profits\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-03-09 08:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> AFT Pharmaceuticals (ASX:AFP, NZE:AFT) said that the court of appeal has dismissed PBL Solutions' bid to claim a share of profits from the company's use of its topical skin medicine Pascomer for treating port wine stains (PWS), according to a Monday filing with the Australian and New Zealand bourses.</p><p>The ruling allows the company to retain full profits from Pascomer's use in treating non-orphan conditions like PWS, per the filing.</p><p>PBL, holding a 35% stake in AFT Orphan Pharmaceuticals, will receive 35% of any profits from Pascomer orphan drug applications, the filing said.</p><p>PBL and the company will share the appeal costs, and the company does not expect the judgment to materially affect its fiscal year 2026 earnings guidance, the filing added.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PWS","symbol_name":"Pacer WealthShield ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2618692420","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618692420","pubTimestamp":1773015366,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"AFT Pharmaceuticals  said that the court of appeal has dismissed PBL Solutions' bid to claim a share of profits from the company's use of its topical skin medicine Pascomer for treating port wine stains , according to a Monday filing with the Australian and New Zealand bourses.The ruling allows the company to retain full profits from Pascomer's use in treating non-orphan conditions like PWS, per the filing.PBL, holding a 35% stake in AFT Orphan Pharmaceuticals, will receive 35% of any profits from Pascomer orphan drug applications, the filing said.PBL and the company will share the appeal costs, and the company does not expect the judgment to materially affect its fiscal year 2026 earnings guidance, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PWS":"Pacer WealthShield ETF","AFP.AU":"AFT PHARMACEUTICALS LTD","AFT":"Apollo Senior Floating Rate Fund","BK7096":"制药"},"translate_title":"AFT Pharmaceuticals赢得上诉法院关于Pascomer利润的案件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AFP.AU":1,"PWS":1,"AFT":1.5},"content_text":"AFT Pharmaceuticals (ASX:AFP, NZE:AFT) said that the court of appeal has dismissed PBL Solutions' bid to claim a share of profits from the company's use of its topical skin medicine Pascomer for treating port wine stains (PWS), according to a Monday filing with the Australian and New Zealand bourses.The ruling allows the company to retain full profits from Pascomer's use in treating non-orphan conditions like PWS, per the filing.PBL, holding a 35% stake in AFT Orphan Pharmaceuticals, will receive 35% of any profits from Pascomer orphan drug applications, the filing said.PBL and the company will share the appeal costs, and the company does not expect the judgment to materially affect its fiscal year 2026 earnings guidance, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}